Polypipe remains a strategically well-placed business with leading positions in its building materials market segments supported by long-term drivers. Actions taken – including the £120m equity raise in May – will aid the company’s ability to absorb the disruptive effects of COVID-19 while retaining operational flexibility to rebuild revenues. The companies forward guidance and our estimates are also remain withdrawn for the time being.
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.